Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Biofrontera (BFRIW) Leases (2022 - 2025)

Biofrontera has reported Leases over the past 4 years, most recently at $1.6 million for Q4 2025.

  • Quarterly results put Leases at $1.6 million for Q4 2025, up 75.42% from a year ago — trailing twelve months through Dec 2025 was $1.6 million (up 75.42% YoY), and the annual figure for FY2025 was $1.6 million, up 75.42%.
  • Leases for Q4 2025 was $1.6 million at Biofrontera, up from $488000.0 in the prior quarter.
  • Over the last five years, Leases for BFRIW hit a ceiling of $1.6 million in Q4 2023 and a floor of $488000.0 in Q3 2025.
  • Median Leases over the past 4 years was $1.2 million (2023), compared with a mean of $1.1 million.
  • Peak annual rise in Leases hit 75.42% in 2025, while the deepest fall reached 54.86% in 2025.
  • Biofrontera's Leases stood at $1.4 million in 2022, then increased by 17.24% to $1.6 million in 2023, then plummeted by 43.98% to $903000.0 in 2024, then skyrocketed by 75.42% to $1.6 million in 2025.
  • The last three reported values for Leases were $1.6 million (Q4 2025), $488000.0 (Q3 2025), and $729000.0 (Q2 2025) per Business Quant data.